Optipharm.CO.,LTD Statistics

Total Valuation

KOSDAQ:153710 has a market cap or net worth of KRW 71.59 billion. The enterprise value is 71.40 billion.

Market Cap	71.59B
Enterprise Value	71.40B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:153710 has 14.67 million shares outstanding. The number of shares has increased by 0.38% in one year.

Current Share Class	14.67M
Shares Outstanding	14.67M
Shares Change (YoY)	+0.38%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	6.68%
Owned by Institutions (%)	n/a
Float	8.62M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.53
PB Ratio	2.71
P/TBV Ratio	2.75
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-26.81
EV / Sales	3.52
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-17.77

Financial Position

The company has a current ratio of 1.27, with a Debt / Equity ratio of 0.41.

Current Ratio	1.27
Quick Ratio	1.02
Debt / Equity	0.41
Debt / EBITDA	n/a
Debt / FCF	-2.72
Interest Coverage	-5.10

Financial Efficiency

Return on equity (ROE) is -10.50% and return on invested capital (ROIC) is -4.66%.

Return on Equity (ROE)	-10.50%
Return on Assets (ROA)	-4.00%
Return on Invested Capital (ROIC)	-4.66%
Return on Capital Employed (ROCE)	-9.18%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.48
Inventory Turnover	8.90

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -26.36% in the last 52 weeks. The beta is 0.11, so KOSDAQ:153710's price volatility has been lower than the market average.

Beta (5Y)	0.11
52-Week Price Change	-26.36%
50-Day Moving Average	5,161.80
200-Day Moving Average	5,206.45
Relative Strength Index (RSI)	25.07
Average Volume (20 Days)	11,232

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:153710 had revenue of KRW 20.25 billion and -2.66 billion in losses. Loss per share was -181.31.

Revenue	20.25B
Gross Profit	5.00B
Operating Income	-2.72B
Pretax Income	-2.66B
Net Income	-2.66B
EBITDA	-1.08B
EBIT	-2.72B
Loss Per Share	-181.31

Full Income Statement

Balance Sheet

The company has 11.11 billion in cash and 10.92 billion in debt, giving a net cash position of 193.80 million or 13.21 per share.

Cash & Cash Equivalents	11.11B
Total Debt	10.92B
Net Cash	193.80M
Net Cash Per Share	13.21
Equity (Book Value)	26.37B
Book Value Per Share	1,797.77
Working Capital	3.90B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.25 billion and capital expenditures -2.77 billion, giving a free cash flow of -4.02 billion.

Operating Cash Flow	-1.25B
Capital Expenditures	-2.77B
Free Cash Flow	-4.02B
FCF Per Share	-273.85

Full Cash Flow Statement

Margins

Gross margin is 24.67%, with operating and profit margins of -13.44% and -13.15%.

Gross Margin	24.67%
Operating Margin	-13.44%
Pretax Margin	-13.15%
Profit Margin	-13.15%
EBITDA Margin	-5.34%
EBIT Margin	-13.44%
FCF Margin	n/a

Dividends & Yields

KOSDAQ:153710 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.38%
Shareholder Yield	n/a
Earnings Yield	-3.72%
FCF Yield	-5.61%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KOSDAQ:153710 has an Altman Z-Score of 2.3 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.3
Piotroski F-Score	3